DK1249241T3 - Adsorbent til oral indgivelse - Google Patents

Adsorbent til oral indgivelse

Info

Publication number
DK1249241T3
DK1249241T3 DK02007918T DK02007918T DK1249241T3 DK 1249241 T3 DK1249241 T3 DK 1249241T3 DK 02007918 T DK02007918 T DK 02007918T DK 02007918 T DK02007918 T DK 02007918T DK 1249241 T3 DK1249241 T3 DK 1249241T3
Authority
DK
Denmark
Prior art keywords
units
lowered
gpt
adsorbent
meq
Prior art date
Application number
DK02007918T
Other languages
Danish (da)
English (en)
Inventor
Naohiro Sonobe
Michihito Ise
Susumu Morimoto
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Application granted granted Critical
Publication of DK1249241T3 publication Critical patent/DK1249241T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Steroid Compounds (AREA)
DK02007918T 2001-04-11 2002-04-09 Adsorbent til oral indgivelse DK1249241T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001112264A JP3522708B2 (ja) 2001-04-11 2001-04-11 経口投与用吸着剤
CA2433368A CA2433368C (en) 2001-04-11 2003-06-25 Adsorbent for oral administration

Publications (1)

Publication Number Publication Date
DK1249241T3 true DK1249241T3 (da) 2007-10-22

Family

ID=34227260

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02007918T DK1249241T3 (da) 2001-04-11 2002-04-09 Adsorbent til oral indgivelse

Country Status (8)

Country Link
US (1) US20020176840A1 (OSRAM)
EP (1) EP1249241B9 (OSRAM)
JP (1) JP3522708B2 (OSRAM)
AT (1) ATE365558T1 (OSRAM)
CA (1) CA2433368C (OSRAM)
DE (2) DE60220849D1 (OSRAM)
DK (1) DK1249241T3 (OSRAM)
ES (1) ES2288176T3 (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6830753B2 (en) 2001-04-11 2004-12-14 Kureha Chemical Industry Co., Ltd. Adsorbent for oral administration
EP1407772B9 (en) * 2002-10-09 2007-02-21 Kureha Corporation Pharmaceutical composition comprising porous spherical carbonaceous substance and its use for the treatment of renal and liver diseases
DE60323112D1 (de) * 2002-11-01 2008-10-02 Kureha Corp Adsorbentien zur oralen verabreichung
US7651974B2 (en) 2002-11-01 2010-01-26 Kureha Chemical Industry Co., Ltd. Adsorbent for oral administration
RU2292211C2 (ru) * 2002-11-01 2007-01-27 Куреха Корпорейшн Адсорбент для перорального введения и средство для лечения или предупреждения заболевания почек или заболевания печени
JP3585043B2 (ja) * 2003-01-22 2004-11-04 メルク・ホエイ株式会社 医薬用吸着剤及びその製法
WO2004089384A1 (ja) * 2003-04-03 2004-10-21 Kureha Chemical Industry Co. Ltd. 低代謝回転骨症の治療又は予防剤
AU2003204621B8 (en) * 2003-06-11 2010-04-22 Kureha Corporation Adsorbent for oral administration
KR101135260B1 (ko) * 2003-10-22 2012-04-12 가부시키가이샤 쿠레하 경구투여용 흡착제, 신질환 치료 또는 예방제 및 간질환치료 또는 예방제
TWI370012B (en) * 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
TWI370013B (en) 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
TWI385120B (zh) * 2004-04-02 2013-02-11 Kureha Corp 球狀活性碳之製造方法
WO2005110444A1 (ja) * 2004-05-18 2005-11-24 Kureha Corporation 眼疾患の治療又は予防剤
CN1964727A (zh) * 2004-06-02 2007-05-16 株式会社吴羽 循环器官功能障碍因子除去剂
US9161557B2 (en) 2004-06-07 2015-10-20 Kureha Corporation Dry composition for oral ingestion and gel composition prepared just before use for oral ingestion
JP4693030B2 (ja) * 2004-11-08 2011-06-01 オルガノ株式会社 活性炭の製造方法
JPWO2006123618A1 (ja) * 2005-05-16 2008-12-25 株式会社クレハ 酸化ストレス抑制剤
JP2007045775A (ja) * 2005-08-11 2007-02-22 Japan Organo Co Ltd 含水活性炭及びその製造方法
US8247072B2 (en) 2006-02-14 2012-08-21 Eastman Chemical Company Resol beads, methods of making them and methods of using them
DE102008014109A1 (de) * 2008-03-13 2009-09-17 Bayer Animal Health Gmbh Suspensionsformulierung für Kohlenstoff-Adsorbentien
JP2010106007A (ja) * 2008-08-14 2010-05-13 Sony Corp 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
WO2010086985A1 (ja) * 2009-01-29 2010-08-05 旭有機材工業株式会社 経口投与用吸着剤
JP5376592B2 (ja) * 2009-10-15 2013-12-25 産協企業有限股▲ふん▼公司 球形活性炭及びその製造方法
JP5765649B2 (ja) 2010-03-10 2015-08-19 株式会社ダステック 吸着炭及び吸着剤
JP5984352B2 (ja) 2010-10-12 2016-09-06 フタムラ化学株式会社 経口投与用医薬用吸着剤の製造方法
PH12013501828A1 (en) 2011-03-04 2013-10-14 Kureha Corp Tablet-formed pharmaceutical composition for oral administration and method for producing same
GB201204696D0 (en) 2012-03-16 2012-05-02 Ucl Business Plc Therapy
CN105688832A (zh) * 2016-03-08 2016-06-22 东南大学 一种低成本改性烟草焦脱汞吸附剂的制备方法
JP7228498B2 (ja) 2018-10-24 2023-02-24 フタムラ化学株式会社 フェノール樹脂の製造方法
CN109135791A (zh) * 2018-10-24 2019-01-04 山西新华化工有限责任公司 工业化的沥青融并成球的制备方法
WO2020213559A1 (ja) 2019-04-16 2020-10-22 フタムラ化学株式会社 活性炭吸着剤の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761284A (en) * 1977-12-27 1988-08-02 Kureha Kagaku Kogy Kabushiki Kaisha Antidote including activated carbon particles
JPS5489010A (en) * 1977-12-27 1979-07-14 Kureha Chem Ind Co Ltd Spherical activated charcoal antidote
JPS565313A (en) * 1979-06-26 1981-01-20 Kureha Chem Ind Co Ltd Detoxificating spherical active carbon and preparing the same
JPS62223125A (ja) * 1979-06-26 1987-10-01 Kureha Chem Ind Co Ltd 経口解毒剤
JPS5673542A (en) * 1979-11-22 1981-06-18 Kureha Chem Ind Co Ltd Adsorbent
CA2162086A1 (en) * 1994-11-15 1996-05-16 Michihito Ise Agent for reducing nephrotoxicity due to medicine
JPH08208491A (ja) * 1994-11-15 1996-08-13 Kureha Chem Ind Co Ltd 薬剤の腎毒性軽減剤

Also Published As

Publication number Publication date
DE60220849T2 (de) 2007-10-25
CA2433368A1 (en) 2004-12-25
EP1249241B1 (en) 2007-06-27
JP2002308785A (ja) 2002-10-23
DE60220849T4 (de) 2008-06-05
CA2433368C (en) 2011-07-05
ATE365558T1 (de) 2007-07-15
EP1249241B9 (en) 2008-06-25
EP1249241A1 (en) 2002-10-16
US20020176840A1 (en) 2002-11-28
JP3522708B2 (ja) 2004-04-26
DE60220849D1 (de) 2007-08-09
ES2288176T3 (es) 2008-01-01

Similar Documents

Publication Publication Date Title
DK1249241T3 (da) Adsorbent til oral indgivelse
TW200517139A (en) Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
DE60220403D1 (de) Zusammensetzung zur unterdrückung von magensäure
DE60021749D1 (de) Pharmazeutische formulierung enthaltend tolterodin sowie ihre verwendung
CA2432085A1 (en) Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
WO2000072838A1 (en) New use of compounds as antibacterial agents
EE200100161A (et) Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid
EP0311244B1 (en) Complex of magnesium oxide and titanium dioxide as a phosphate adsorbent
IL146025A (en) Dissolving drug containing ritonavir and organic solvent containing a mixture of long-chain fatty acids ethanol and water
JP2002521468A5 (OSRAM)
IS3789A7 (is) Aðferð við framleiðslu lyfjaskammta í föstu formimeð tempraðri losun virks þáttar
CA2306748A1 (en) Treatment of fibromyalgia and related disorders
SE8500996D0 (sv) Method of treatment
DE69530429D1 (de) Catecholdiether-derivate verwendbar als pharmazeutische mittel
AU2002358819A1 (en) Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen
CA2344910A1 (en) Method for treating renal disease, and pharmaceutical composition for treating renal disease
EP1323422B8 (en) Pharmaceutical composition comprising midazolam for buccal administration
ATE335495T1 (de) Pharmazeutische zubereitung enthaltend poröse sphärische kohlenstoffhaltige teilchen und deren verwendung zur behandlung von leber- und nierenerkrankungen
ATE319434T1 (de) Pharmazeutische zusammensetzung für die kontrollierte freisetzung eines beta-lactam- antibiotikums
JP2006111604A5 (OSRAM)
Rosowsky et al. Methotrexate analogues—XVII: Antitumor activity of 4-amino-4-deoxy-N10-methylpteroyl-d, l-homocysteic acid and its dual inhibition of dihydrofolate reductase and folyl polyglutamate synthetase
RU2003135201A (ru) Применение антагониста опиоидов налтрексона для предупреждения и контроля побочных воздействий, вызванных опиоидами
TW200500084A (en) Adsorbent for oral administration and pharmaceutical composition, and method of manufacturing absorbent for oral administration
EP0916663A1 (en) 18Beta, 19Beta-diacetyloxy-18Alpha, 19Alpha-epoxy-3,13(16), 14-clerodatrien-2-one (Esculentin A) and 18Beta, 19Beta-diacetyloxy-18Alpha, 19Alpha-epoxy-3, 12, 14-clerodatrien-2Beta-isovaleryloxy-6Beta, 7Alpha-diol (Esculentin B), a process for their preparation, and their use in the manufacture of medicaments
NO20016255L (no) Kromeno[4,3,2-de]isoquinoline som potente dopamineresepter ligander